Selection and vitrification of embryos with a poor morphological score: A proposal to avoid embryo wastage

Abstract

Embryos with a poor morphological score at cleavage stage are usually discarded because they are considered unsuitable for transfer and cryopreservation. This study examined the in vitro blastocyst development after extended culture of these embryos and the clinical outcomes after transfer of these blastocysts in warming cycles. A total of 597 blastocysts (24.7%) were obtained from 2421 embryos with low morphological scores after extended culture. One hundred and sixty blastocysts (6.6%) with optimal morphology were vitrified. Embryo utilization rate was increased from 30.8% to 32.6%. After warming, 61 out of 92 blastocysts (66.3%) survived and were transferred in 44 cycles. The clinical pregnancy rate and the implantation rate were 40.9% (18/44) and 32.8% (20/61) respectively. Thirteen healthy babies were born, and 5 pregnancies aborted spontaneously. Our study suggested that some blastocysts derived from embryos with a poor morphological score can be successfully vitrified and give rise to live births. Selection and vitrification of viable embryos after extended culture of embryos with a poor morphological score may constitute a proposal to avoid embryo wastage.

Keywords

blastocyst / extended culture / low morphological score / vitrification

References

[1] SakkasD., LuC., ZulfikarogluE., et al.. A soluble molecule secreted by human blastocysts modulates regulation of HOXA10 expression in an epithelial endometrial cell line. Fertil Steril, 2003, 80(5): 1169-1174

[2] SherG., KeskintepeL., FischJ.D., et al.. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril, 2005, 83(5): 1410-1143

[3] VergouwC.G., BotrosL.L., RoosP., et al.. Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection. Hum Reprod, 2008, 23(7): 1499-1504

[4] Katz-JaffeM.G., GardnerD.K., SchoolcraftW.B.. Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertil Steril, 2006, 85(1): 101-107

[5] AssouS., HaouziD., De VosJ., et al.. Human cumulus cells as biomarkers for embryo and pregnancy outcomes. Mol Hum Reprod, 2010, 16(8): 531-538

[6] SeliE., RobertC., SirardM.A.. OMICS in assisted reproduction: possibilities and pitfalls. Mol Hum Reprod, 2010, 16(8): 513-530

[7] GardnerD.K., LaneM., StevensJ., et al.. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril, 2000, 73(6): 1155-1158

[8] GrahamJ., HanT., PorterR., et al.. Day 3 morphology is a poor predictor of blastocyst quality in extended culture. Fertil Steril, 2000, 74(3): 495-497

[9] GuerifF., Le GougeA., GiraudeauB., et al.. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod, 2007, 22(7): 1973-1981

[10] RijndersP.M., JansenC.A.. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod, 1998, 13(10): 2869-2873

[11] AlikaniM., CalderonG., TomkinG., et al.. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod, 2000, 15(12): 2634-2643

[12] HardyK., StarkJ., WinstonR.M.. Maintenance of the inner cell mass in human blastocysts from fragmented embryos. Biol Reprod, 2003, 68(4): 1165-1169

[13] RacowskyC., CombellesC.M., NureddinA., et al.. Day 3 and day 5 morphological predictors of embryo viability. Reprod Biomed Online, 2003, 6(3): 323-331

[14] StrömS., Rodriguez-WallbergK., HolmF., et al.. No relationship between embryo morphology and successful derivation of human embryonic stem cell lines. PLoS One, 2010, 5(12): e15329

[15] AlikaniM., MunnéS.. Nonviable human pre-implantation embryos as a source of stem cells for research and potential therapy. Stem Cell Rev, 2005, 1(4): 337-343

[16] ChenH., QianK., HuJ., et al.. The derivation of two additional human embryonic stem cell lines from day 3 embryos with low morphological scores. Hum Reprod, 2005, 20(8): 2201-2206

[17] FanY., LuoY., ChenX., et al.. A modified culture medium increases blastocyst formation and the efficiency of human embryonic stem cell derivation from poor-quality embryos. J Reprod Dev, 2010, 56(5): 533-539

[18] HardarsonT., CaisanderG., SjögrenA., et al.. A morphological and chromosomal study of blastocysts developing from morphologically suboptimal human pre-embryos compared with control blastocysts. Hum Reprod, 2003, 18(2): 399-407

[19] PatrizioP., SakkasD.. From oocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilization. Fertil Steril, 2009, 91(4): 1061-1066

[20] KovalevskyG., PatrizioP.. High rates of embryo wastage with use of assisted reproductive technology: a look at the trends between 1995 and 2001 in the United States. Fertil Steril, 2005, 84(2): 325-330

[21] LiuQ., ZhuG., HuJ., et al.. Relationship between pronuclear scoring and embryo quality and implantation potential in IVF-ET. J Huazhong Univ Sci Technolog [Med Sci], 2008, 28(2): 204-206

[22] SteerC.V., MillsC.L., TanS.L., et al.. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod, 1992, 7(1): 117-119

[23] AliJ., SheltonJ.N.. Design of vitrification solutions for the cryopreservation of embryos. J Reprod Fertil, 1993, 99(2): 471-477

[24] HiraokaK., HiraokaK., KinutaniM., et al.. Blastocoele collapse by micropipetting prior to vitrification gives excellent survival and pregnancy outcomes for human day 5 and 6 expanded blastocysts. Hum Reprod, 2004, 19(12): 2884-2888

[25] MukaidaT., NakamuraS., TomiyamaT., et al.. Vitrification of human blastocysts using cryoloops: clinical outcome of 223 cycles. Hum Reprod, 2003, 18(2): 384-391

[26] EsfandiariN., CasperR.F., MoskovtsevS., et al.. Cryopreservation of supernumerary day-3 embryos with poor quality: is there any benefit for extending culture to blastocyst before freezing?. Fertil Steril, 2003, 80(S3): s146

[27] SaragustyJ., AravA.. Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reproduction, 2011, 141(1): 1-19

[28] KovacicB., VlaisavljevicV., ReljicM., et al.. Developmental capacity of different morphological types of day 5 human morulae and blastocysts. Reprod Biomed Online, 2004, 8(6): 687-694

[29] SathananthanH., MenezesJ., GunasheelaS., et al.. Mechanics of human blastocyst hatching in vitro. Reprod Biomed Online, 2003, 7(2): 228-234

[30] SomfaiT., InabaY., AikawaY., et al.. Relationship between the length of cell cycles, cleavage pattern and developmental competence in bovine embryos generated by in vitro fertilization or parthenogenesis. J Reprod Dev, 2010, 56(2): 200-207

[31] Eftekhari-YazdiP., ValojerdiM.R., AshtianiS.K., et al.. Effect of fragment removal on blastocyst formation and quality of human embryos. Reprod Biomed Online, 2006, 13(6): 823-832

[32] SagoskinA.W., HanT., GrahamJ.R., et al.. Healthy twin delivery after day 7 blastocyst transfer coupled with assisted hatching. Fertil Steril, 2002, 77(3): 615-617

[33] SillsE.S., SweitzerC.L., MortonP.C., et al.. Dizygotic twin delivery following in vitro fertilization and transfer of thawed blastocysts cryopreserved at day 6 and 7. Fertil Steril, 2003, 79(2): 424-427

[34] HiraokaK., FuchiwakiM., HiraokaK., et al.. Vitrified human day-7 blastocyst transfer: 11 cases. Reprod Biomed Online, 2008, 17(5): 689-694

[35] HiraokaK., FujimotoY., TateakiY., et al.. Case report: two successful pregnancies following the transfer of re-vitrified human day 7 blastocysts developed from vitrified cleaved embryos. J Assist Reprod Genet, 2008, 25(9–10): 503-509

[36] HiraokaK., HiraokaK., HoriuchiT., et al.. Case report: successful delivery following the transfer of a human re-vitrified day-7 spontaneously hatched blastocyst developed from vitrified cleaved embryos. J Assist Reprod Genet, 2009, 26(7): 405-409

[37] ManipalviratnS., DeCherneyA., SegarsJ.. Imprinting disorders and assisted reproductive technology. Fertil Steril, 2009, 91(2): 305-315